Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sipowicz, M. A.
Right arrow Articles by Rice, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sipowicz, M. A.
Right arrow Articles by Rice, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 233-236, Copyright © 1997 by Oxford University Press

ARTICLES

Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice

MA Sipowicz, CM Weghorst, YH Shiao, GS Buzard, RJ Calvert, MR Anver, LM Anderson and JM Rice
Laboratory of Comparative Carcinogenesis, National Cancer Institute- FCRDC, Frederick, MD 21702, USA.

Helicobacter hepaticus is a recently discovered bacterium that invades mouse liver causing chronic active hepatitis followed by development of preneoplastic hepatocellular foci, hepatocellular adenomas and carcinomas. This establishes a unique animal model for study of the mechanisms of cancer development due to a chronic bacterial infection. A possible mechanism of bacteria-associated tumorigenesis is mutation of oncogenes or tumor suppressor genes. Since mutations in ras oncogenes have been widely detected in a variety of chemically induced and spontaneous mouse liver tumors and specific mutations in the p53 tumor suppressor gene have been associated with human bladder cancers attributed to chronic schistosomal infection, we studied exons 1 and 2 of the N-, K- and H-ras genes and exons 5-8 of the p53 gene for the presence of point mutations in 25 liver tumors from 10 naturally infected A/JCr mice, ranging in age from 16 to 24 months. The 20 adenomas and five carcinomas varied in size from 0.1 to 2.3 cm and arose in livers characterized by a wide assortment of pathological profiles, including hepatitis, inflammation, hyperplasia, hypertrophy, leukocyte infiltration, necrosis and focal phenotypic alteration. DNA samples extracted from formalin-fixed paraffin-embedded tissues were screened by PCR/SSCP analysis and showed no mutations in the analyzed genes. Complete absence of mutations in ras genes in 25 mouse liver tumors is unusual. Other genes may be targeted or H. hepaticus infection causes liver cancer through other pathways than direct damage to DNA.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
L. Maggio-Price, P. Treuting, W. Zeng, M. Tsang, H. Bielefeldt-Ohmann, and B. M. Iritani
Helicobacter Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice
Cancer Res., January 15, 2006; 66(2): 828 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Maggio-Price, H. Bielefeldt-Ohmann, P. Treuting, B. M. Iritani, W. Zeng, A. Nicks, M. Tsang, D. Shows, P. Morrissey, and J. L. Viney
Dual Infection with Helicobacter bilis and Helicobacter hepaticus in P-Glycoprotein-Deficient mdr1a-/- Mice Results in Colitis that Progresses to Dysplasia
Am. J. Pathol., June 1, 2005; 166(6): 1793 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
S. R. Boutin, A. B. Rogers, Zeli Shen, R. C. Fry, J. A. Love, P. R. Nambiar, S. Suerbaum, and J. G. Fox
Hepatic Temporal Gene Expression Profiling in Helicobacter hepaticus-Infected A/JCr Mice
Toxicol Pathol, October 1, 2004; 32(6): 678 - 693.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
R.R. Maronpot, G. Flake, and A. J. Huff
Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention
Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48.
[Abstract] [PDF]

Home page
 J. Clin. Microbiol.Home page
J. G. Fox, Z. Shen, S. Xu, Y. Feng, C. A. Dangler, F. E. Dewhirst, B. J. Paster, and J. M. Cullen
Helicobacter marmotae sp. nov. Isolated from Livers of Woodchucks and Intestines of Cats
J. Clin. Microbiol., July 1, 2002; 40(7): 2513 - 2519.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Singh, C. Leuratti, S. Josyula, M. A. Sipowicz, B. A. Diwan, K. S. Kasprzak, H. A. J. Schut, L. J. Marnett, L. M. Anderson, and D. E. G. Shuker
Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus
Carcinogenesis, August 1, 2001; 22(8): 1281 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
J. V. Solnick and D. B. Schauer
Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases
Clin. Microbiol. Rev., January 1, 2001; 14(1): 59 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. R. Hailey, J. K. Haseman, J. R. Bucher, E. Radovsky, D. E. Malarkey, R. T. Miller, A. Nyska, and R. R. Maronpot
Impact of Helicobacter hepaticus Infection in B6C3F1 Mice from Twelve National Toxicology Program Two-Year Carcinogenesis Studies
Toxicol Pathol, September 1, 1998; 26(5): 602 - 611.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
B. A. Diwan, J. M. Ward, D. Ramljak, and L. M. Anderson
Promotion by Helicobacter hepaticus-Induced Hepatitis of Hepatic Tumors Initiated by N-Nitrosodimethylamine in Male A/JCr Mice
Toxicol Pathol, November 1, 1997; 25(6): 597 - 605.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.